Bibliothèque de vidéos et webinaires

[ESMO24] Evolving role of genomic assays in early breast cancer

Prof. Miguel Martin discusses the application of genomic assays in the neoadjuvant setting

[ESMO24] Tissue-based genomics to guide adjuvant therapy decisions

Prof. Janice Walshe discusses the impact of the introduction of genomic assays on clinical practice for both clinicians and patients.

[ESMO24] Introduction to MRD in breast cancer

Prof. Nicholas Turner provides a brief overview of the concept and terms related to molecular residual disease.

[ESMO24] Evolving role of MRD guided decision making in early breast cancer

Prof. Sherene Loi presented at ESMO 2024 an update on the current data and ongoing studies on molecular residual disease in early breast cancer.

[ESMO24] Optimizing the approach to MRD assay development

Rick Baehner provides a topline overview of ongoing research into the development of MRD assays.

[EBCC24] Evolving clinical practice for multi-gene assays: what’s new!

Evolving clinical practice for multi-gene assays: what’s new!

[EBCC24] Implications of updated guidelines for MGAs: Introduction

Implications of updated guidelines for MGAs: Introduction

[EBCC24] Implementation of guidelines into clinical practice: expert discussion on challenging cases - Large tumour

Implementation of guidelines into clinical practice: expert discussion on challenging cases - Large tumour

[EBCC24] Implementation of guidelines into clinical practice: expert discussion on challenging cases - Elderly patient

Professor Laura Biganzoli presented a challenging case study of an elderly patient with early breast cancer, focusing on the important interplay between genomic tools and patients’ characteristics.

[EBCC24] Challenging cases: N1 – premenopausal

Professor Christian Kurzeder presented a challenging case study of a N1 premenopausal patient, focusing on how ODX and clinical evidence may help...